Novo CEO pressed by Senate to chop prices of obesity, diabetes medications CEO Lars Fruergaard Jørgensen told lawmakers the corporate would look at new talks with insurers concerning the list costs of Wegovy and copyright if they pledge to keep the medicines on their formularies. This strategy aligns with Individuals https://kethek.com/